The Magazine for Sleep Professionals
Tuesday, September 1, 2026
SleepOvation Baby, an FDA-registered manufacturer of medical devices, today announced that its crib mattress has been listed by the FDA for sale. With this listing, parents can shop with confidence knowing that SleepOvation Baby’s crib mattress is safe and effective for babies. “SleepOvation Baby is thrilled to obtain this FDA […]
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces the FDA approval to remove dental contraindications for eXciteOSA. This opens the door for doctors and other providers to prescribe eXciteOSA on a more widespread basis. Based on an observational study conducted by Signifier Medical, the […]
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides recommendations for the management of REM sleep behavior disorder in adults. The guideline, available online as an accepted paper in the Journal of Clinical Sleep Medicine, updates the AASM’s previous guidance published in 2010. Several clinical trials […]
React Health is pleased to announce that it has entered into a distribution agreement with SleepRes, LLC to provide the recently launched V-Com™ with new PAP orders in the United States. The V-Com™, which is placed between the CPAP mask and the CPAP hose, is engineered to reduce inspiratory pressure […]
Belgium-based scale-up, Sunrise, announced today the U.S. Food and Drug Administration (FDA) has cleared for use of its second-generation at-home sleep apnea test that uses artificial intelligence (AI) to aid in the diagnosis of obstructive sleep apnea and sleep-related breathing disorders. The Sunrise team is using a novel way to measure […]
The Board of Registered Polysomnographic Technologists (BRPT) named Amber Allen, BA, RPSGT, RST, CCSH President-Elect of the Board of Directors. Her two-year term as President will begin in January 2024. Allen has been a member of the BRPT Board since 2017, serving as Secretary as well as Chair of the […]
Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies to treat obstructive sleep apnea (OSA) and related disorders, announced positive topline results from the MARIPOSA Phase 2b trial, an efficacy, safety and dose-finding study of one-month duration. The topline results were positive for the company’s lead candidate for […]
Emmanuel Mignot, MD, PhD, the Craig Reynolds Professor of Sleep Medicine, is the winner of a 2023 Breakthrough Prize in Life Sciences. He will share the $3 million prize with Masashi Yanagisawa, MD, PhD, of the University of Tsukuba for discovering the causes of narcolepsy and paving the way for […]
The U.S. Food and Drug Administration (FDA) is alerting patients, caregivers, and health care providers that Philips Respironics (Philips) recalled certain bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP) machines that may contain a plastic contaminated with a non-compatible material. If that plastic is in the […]
SleepRes, LLC, the developers of the V̇-Com™, announces Bernard Hete, Ph.D. as their Chief Technology Officer to oversee future research and development. Dr. Hete has been a senior engineer at Philips Respironics for 30 years. “I get to work with a visionary sleep physician who is revolutionizing PAP therapy to […]
